Determination of Tedizolid Susceptibility Interpretive Criteria for Gram-Positive Pathogens According to Clinical and Laboratory Standards Institute Guidelines

This article summarizes the key components used to establish the Clinical Laboratory Standards Institute (CLSI) breakpoints for tedizolid. First, in vitro studies using recent surveillance and clinical trial isolates ascertained minimal inhibitory concentration (MIC) distributions against pertinent organisms, including staphylococci, streptococci, and enterococci.

Source: Diagnostic Microbiology and Infectious Disease - November 7, 2017 Category: Microbiology Authors: Mekki Bensaci, Shawn Flanagan, Taylor Sandison Source Type: research